Oncology Venture competitorsClear all

Oncology Venture's top competitors include Northwest Biotherapeutics, Merrimack Pharmaceuticals, Genocea Biosciences and Calithera Biosciences.
Oncology Venture
Oncology Venture
Oncology Venture is a drug development company.
Northwest Biotherapeutics
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
Calithera Biosciences
Calithera Biosciences
Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Founding Date
Founding Date
2004
Founding Date
1998
Founding Date
2000
Founding Date
2006
Founding Date
2010
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Hørsholm, DK HQ
Scottsdale, US
Locations
Bethesda, US HQ
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
12
Employees
1721% increase
Employees
2763% decrease
Employees
593% decrease
Employees
798% increase
Valuation ($)
Valuation ($)
34.8 m
Valuation ($)
629 m
Valuation ($)
51.1 m
Valuation ($)
125.8 m
Valuation ($)
256.8 m
Twitter followers
Twitter followers
323
Twitter followers
2.1 k
Twitter followers
1.1 k
Twitter followers
1.5 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
6.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.3
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
262769
Alexa Website Rank
336563
Alexa Website Rank
388656
Alexa Website Rank
187589
Alexa Website Rank
306415
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3
Employee Rating
3.6
Employee Rating
N/A

Financial

Net income
Net income
N/A
Net income
($20.3m) (FY, 2019)
Net income
($17.3m) (FY, 2019)
Net income
($39m) (FY, 2019)
Net income
($89.9m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 929.1k
Total funding raised
$ 135.9m
Total funding raised
$ 79.4m
Total funding raised
$ 209.5m
Total funding raised
$ 105m
For sources of this data, please see the company profile

View company profiles

Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company
Genocea Biosciences
HQ
Cambridge, US
Employees
59↓ 3% decrease

Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.

View company
Calithera Biosciences
HQ
South San Francisco, US
Employees
79↑ 8% increase

Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

View company